U S PHYSICAL THERAPY INC /NV
U.S. Physical Therapy operates outpatient physical therapy, speech therapy and occupational therapy clinics, home-care practices, and industrial injury prevention services. Its physical therapy operations segment treats orthopedic conditions, sports injuries and injured workers, and also provides management and administrative services to hospitals and other therapy providers. The industrial injury prevention services segment offers employers onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. U.S. Physical Therapy generally operates clinics through partnerships with physical therapists and also manages clinics owned by hospitals and other providers. It charges for clinic treatment primarily on a per-procedure basis and earns fees for management and administrative services. Employers directly contract for and pay for the majority of its industrial injury prevention services. On December 31, 2025, it owned and/or managed 780 clinics in 44 states. Its principal executive offices are in Houston, Texas.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $USPH in the last 30 days.
See all $USPH insider activity →U.S. Physical Therapy reported Q3 revenue growth of 13% to $223M, with EBITDA up 16% to $28M. The company reaffirmed its full-year EBITDA guidance of $102M-$106M. Growth was driven by increased physical therapy visits and hospital affiliations, while higher employee health benefit costs impacted margins.
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 U.S. Physical Therapy November 5, 2026 Earnings Call 10:30 am ET Operator: Good day and thank you for standing by. Welcome to the U.S. Physical Therapy third quarter 2026 earnings call. At this time, all participants are in a listen-only mode. After the speaker’s pre
U.S. Physical Therapy (USPH) reported Q3 earnings, with adjusted physical therapy margins rising 60 basis points YoY to 19%, despite higher medical costs. The company plans acquisitions and clinic expansions. Industrial injury prevention revenue grew 14% to $33M. GAAP net income fell to $11M from $13M YoY. USPH ended Q3 with $38M in cash and $247M in borrowings.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning USPH (U S PHYSICAL THERAPY INC /NV). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent USPH coverage spans earnings, corporate actions and insider activity.
Earnings beat on revenue and EBITDA with guidance reaffirmed.
Earnings beat and strong growth metrics suggest upside potential.
Earnings miss and higher expenses likely weigh on the stock.
USPH reported higher revenue but a loss per share, suggesting earnings pressure.
Earnings miss and loss per share likely trigger sell pressure.
AlphAI scores every news story that mentions USPH with an AI model for sentiment and relevance, and aggregates insider trades from U S PHYSICAL THERAPY INC /NV's SEC EDGAR Form 4 filings. Figures refresh continuously.
U.S. Physical Therapy reported Q3 revenue growth of 13% to $223M, with EBITDA up 16% to $28M. The company reaffirmed its full-year EBITDA guidance of $102M-$106M. Growth was driven by increased physical therapy visits and hospital affiliations, while higher employee health benefit costs impacted margins.
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 U.S. Physical Therapy November 5, 2026 Earnings Call 10:30 am ET Operator: Good day and thank you for standing by. Welcome to the U.S. Physical Therapy third quarter 2026 earnings call. At this time, all participants are in a listen-only mode. After the speaker’s pre
U.S. Physical Therapy (USPH) reported Q3 earnings, with adjusted physical therapy margins rising 60 basis points YoY to 19%, despite higher medical costs. The company plans acquisitions and clinic expansions. Industrial injury prevention revenue grew 14% to $33M. GAAP net income fell to $11M from $13M YoY. USPH ended Q3 with $38M in cash and $247M in borrowings.
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit Houston, TX, November 4, 2026 – U.S. Phy
U.S. Physical Therapy reported Q3 2026 revenue of $223M, up 13% YoY, with net income of $6M. Patient visits rose 8% to 1.7M, and revenue per visit hit $111. Adjusted EBITDA increased to $24M. The company declared a $0.46 dividend and reaffirmed its 2026 adjusted EBITDA guidance.
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. ITEM 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, U.S. Physical Therapy, Inc.(the "Company") entered into a 45-month forward-starting interest rate swap agreement (the “Swap”) with Bank of America, National Association (“Bank of America”) with an initia
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy Announces the Appointment of New Board Member My
Minan Peter Francis purchased 6 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $77.23 ($66.50–$79.00) across 2 trades over 2026-06-12 to 2026-09-11.
US Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.
The article highlights Q2 results for outpatient and specialty care firms. Surgery Partners (SGRY) reported slowest revenue growth and weaker full-year guidance, with the stock down 1.4% to $15.32. LifeStance (LFST) revenue rose to $435.4M (+26.1%) and shares rose 18.3% to $12.27. U.S. Physical Therapy (USPH) revenue $214.1M (+8.5%) and shares $81.96. Encompass Health (EHC) revenue $1.60B (+9.6%) and shares $124.69. agilon health (AGL) revenue $1.49B (+7.2%), shares $87.56.
